Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carmustine (bicnu) (1 trial)
lomustine (1 trial)
temozolomide (temodar) (2 trials)
trabedersen (3 trials)
tgf-β2 antisense oligonucleotide (1 trial)
Astrocytoma (Phase 3)
Colorectal Neoplasms (Phase 1)
Glaucoma (Phase 1)
Glaucoma, Open-Angle (Phase 1)
Glioblastoma (Phase 3)
Melanoma (Phase 1)
Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1)
Trials (4 total)
Trial APIs (5 total)